162 related articles for article (PubMed ID: 21138468)
1. Mycosis fungoides in Arab children and adolescents: a report of 36 patients from Kuwait.
Nanda A; AlSaleh QA; Al-Ajmi H; Al-Sabah H; Elkashlan M; Al-Shemmari S; Demierre MF
Pediatr Dermatol; 2010; 27(6):607-13. PubMed ID: 21138468
[TBL] [Abstract][Full Text] [Related]
2. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study.
Wain EM; Orchard GE; Whittaker SJ; Spittle M Sc MF; Russell-Jones R
Cancer; 2003 Nov; 98(10):2282-90. PubMed ID: 14601100
[TBL] [Abstract][Full Text] [Related]
3. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
4. Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991-2006.
Alsaleh QA; Nanda A; Al-Ajmi H; Al-Sabah H; Elkashlan M; Al-Shemmari S; Demierre MF
Int J Dermatol; 2010 Dec; 49(12):1393-8. PubMed ID: 21155090
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
[TBL] [Abstract][Full Text] [Related]
6. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
[TBL] [Abstract][Full Text] [Related]
7. Mycosis Fungoides: Experience in a Pediatric Hospital.
Cervini AB; Torres-Huamani AN; Sanchez-La-Rosa C; Galluzzo L; Solernou V; Digiorge J; Rubio P
Actas Dermosifiliogr; 2017; 108(6):564-570. PubMed ID: 28279399
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
9. [Mycosis fungoides in children and adolescents: a report of six cases with predominantly hypopigmentation, along with a literature review].
Rizzo FA; Vilar EG; Pantaleão L; Fonseca EC; Magrin PF; Henrique-Xavier M; Rochael MC
Dermatol Online J; 2012 Mar; 18(3):5. PubMed ID: 22483516
[TBL] [Abstract][Full Text] [Related]
10. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides.
Khopkar U; Doshi BR; Dongre AM; Gujral S
Indian J Dermatol Venereol Leprol; 2011; 77(2):167-73. PubMed ID: 21393946
[TBL] [Abstract][Full Text] [Related]
11. [Mycosis fungoides in childhood and adolescence with clonal T-cell receptor gamma gene rearrangement. Two cases].
Krokowski M; Winzer M; Lange K; Thorns C; Gafumbegete E; Feller AC; Merz H
Hautarzt; 2003 Jun; 54(6):536-40. PubMed ID: 12759739
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
[TBL] [Abstract][Full Text] [Related]
13. The different faces of mycosis fungoides: results of a single-center study.
Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
[TBL] [Abstract][Full Text] [Related]
14. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
Tan ES; Tang MB; Tan SH
Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
[TBL] [Abstract][Full Text] [Related]
15. Incidence rate of mycosis fungoides in Isfahan (Iran).
Salehi M; Azimi Z; Fatemi F; Rajabi P; Kazemi M; Amini G
J Dermatol; 2010 Aug; 37(8):703-7. PubMed ID: 20649711
[TBL] [Abstract][Full Text] [Related]
16. [Papular mycosis fungoides].
Brajon D; Bonnet N; Dales JP; Berbis P
Ann Dermatol Venereol; 2013; 140(6-7):455-8. PubMed ID: 23773745
[TBL] [Abstract][Full Text] [Related]
17. The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome.
Bi MY; Curry JL; Christiano AM; Hordinsky MK; Norris DA; Price VH; Duvic M
J Am Acad Dermatol; 2011 Jan; 64(1):53-63. PubMed ID: 21036417
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
[TBL] [Abstract][Full Text] [Related]
19. Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis).
El-Darouti MA; Marzouk SA; Azzam O; Fawzi MM; Abdel-Halim MR; Zayed AA; Leheta TM
Eur J Dermatol; 2006; 16(1):17-22. PubMed ID: 16436337
[TBL] [Abstract][Full Text] [Related]
20. Juvenile folliculotropic and ichthyosiform mycosis fungoides.
Ryan C; Whittaker S; D'Arcy C; O'Regan GM; Rogers S
Clin Exp Dermatol; 2009 Jul; 34(5):e160-2. PubMed ID: 19094122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
